BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
read more
The work is fast paced and can be stressful at times, but the science we're working on is cutting edge and very important to change the world of cellular therapies as we know it. The people here are super friendly and open all the time.
What is the best part about your compensation package?
The salary and bonus structure
What is most positive about the culture and environment at your company?
Everyone is very invested in the work that we're doing here at BlueRock
Other Employee Reviews for BlueRock Therapeutics
×